A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Summary

The purpose of this study is to assess safety, tolerability, preliminary efficacy, and PK of TAK-671 in participants with COVID-19.

Timeline

Start

2020-09-25

Primary completion

2020-10-30

Completion

2020-10-30

Outcome

Outcome not reported

Stopped (Enrollment): “Business Decision (no enrollment)”

Drugs

Indications